A safety and Immunological assessment of JRC sensitive (atopic) subjects will be assessed in terms of current skin test reactivity. Subjects that are eligible to participate in this study will be assigned by whether they are sensitive or non sensitive to CryJ2 or Mountain Cedar to one of 3 study vaccine cohorts: